Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 91 for “"Hormonal therapy"”.
-
THE RESPONSE OF THE PROSTATE TUMOR IMMUNE MICROENVIRONMENT TO NEOADJUVANT HORMONAL THERAPY
… disease to men and treatments like chemotherapy and hormonal therapy are often used. Androgen deprivation therapy is a type of hormonal therapy to block androgen activity by inhibiting androgen synthesis or AR transcription factor activity. During our study, androgen deprivation therapy …
-
Factors influencing patient adherence and persistence to hormonal therapy drugs in treatment of breast cancer
… costs and adherence and persistence to hormonal therapy (HT) used in treatment of breast cancer. A retrospective analysis of medical and prescription drug claims for patients with breast cancer (N=6,504) was conducted to estimate the medication possession ratio; adherence; days of …
-
Theory guided integrative systematic review of the psychosocial determinants associated with non-adherence to adjuvant hormonal therapy among breast cancer population
… Suboptimal adherence to 5 years adjuvant hormonal therapy (AHT) is prevalent among people with breast cancer. Non-adherence to prescribed AHT medication is linked to increased recurrence rates, lower survival rates and wasted healthcare resources. Targeting the modifiable psychosocial …
-
The Kras/Mapk Pathway and Ligand Independent Activation of Erα: Implications For The Treatment of Endometrial Cancer
Hormonal therapy remains a first line option for the treatment of recurrent endometrial cancer (EC), however, many tumors demonstrate de novo or acquired resistance. Member kinases of the PI3K/AKT and Ras/MAPK pathways activate estrogen receptor α (ERα) independent of estrogen, however, few studies …
-
Out-Of-Pocket Costs, Subsidies, And The Delivery Of Breast Cancer Care Among Elderly Women
… (HR+) breast cancer initiate adjuvant hormonal therapy with either AIs or tamoxifen. Switching to another therapy drug is an important strategy to manage treatment related side effects. Those diagnosed at early stages should also receive surgery and/or radiation before or after the …
-
Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors In Breast Cancer
… tumors that express hormone receptors and need hormonal therapy. Aromatase inhibitors (AIs) block estrogen biosynthesis and are considered as the first line hormonal therapy for ER+ post-menopausal patients. However, resistance to these drugs remains a major challenge in clinic and the biology …
-
Menopause and cardiovascular, metabolic and bone parameters
… thesis investigates the effects of exercise, hormonal therapy (HT) and rosiglitazone on cardiovascular risk variables, glucose and insulin levels and bone turnover markers. It was hypothesised that these interventions would independentiy improve parameters measured, whilst combined treatment …
-
Women's experiences of breast cancer and spiritual healing: a unitary appreciative inquiry.
… of women with breast cancer receiving long-term hormonal therapy. Background Spiritual Healing is widely available and used by many but is a neglected area of research. Whilst the exact mechanisms are not understood and healers make no claim to cure, evidence suggested that Spiritual Healing as a …
-
Εκτίμηση της προβλεπτικής και προγνωστικής σημασίας του mTOR (mammalian Target Of Rapamycin) σε ασθενείς με καρκίνο του μαστού
… 997 patients participating in two adjuvant chemotherapy phase III trials were assessed by immunohistochemistry (IHC) for EGFR, PTEN, p-Akt, p-mTOR and single nucleotide polymorphism (SNP) genotyping for PIK3CA mutations. These markers were correlated with selected patients and tumor …
-
Epigenetic Targeting to Deplete Cytostatic Breast cancer cells under Endocrine Therapy
… (ER) and are dependent on estrogen to grow. Hormonal therapies using selective estrogen receptor modulators, such as tamoxifen, are frequently used to treat ER+ breast cancer. Tamoxifen treatments have shown efficacy in managing ER+ breast cancer, but approximately 30% of patients relapse …
-
BAG-1 expression and function in breast cancer
… 138 patients with breast cancer treated with hormonal therapy were analysed by immunohistochemistry. Nuclear BAG-1 immunostaining was associated with expression of oestrogen receptor alpha and progesterone receptor and with improved survival. Reporter gene assays were used to determine the …
-
Glycans and Glycoconjugates as Biomarkers and Therapeutic Targets for Therapy-Resistant Prostate Cancer
… or metastatic disease requiring the use of hormonal therapy. Despite being initially successful, all men treated with hormonal therapy will eventually develop castration-resistant PCa (CRPC) in which the tumor cells are able to actively proliferate and metastasize despite continued androgen …
-
Understanding the Tumor Suppressive Functions of Estrogen Receptor β in Breast Cancer
… PR, and Her2, and there is no effective targeted therapy. Despite the lack of ERα, a significant number of TNBCs express ERβ. ERβ1 displays anti-migratory, anti-invasive, and anti-metastatic properties. However, the mechanism underlying its function is not well understood. Using molecular …
-
Exploring endometrial cellular heterogeneity and its role in endometriosis using single-cell transcriptomics
… menstrual cycles and when taking exogenous hormonal therapy. I hypothesised that by analysing a large set of endometrial biopsies we can uncover novel cell populations and disease-specific transcriptomic signatures.</p> <p>The single-cell map presented in this thesis consists of ~600,000 …
-
The Effect of Various Experimental Factors and Adrenocorticotrophic Hormones on the Spreading Effect of Hyaluronidases
… been in evidence in the absence of substitution hormonal therapy. [TRUNCATED]
-
Investigations into the effects of traditional Chinese medicinal herbs used in the treatment of human breast cancer
… treatment (surgery, radio-, chemo- and/or hormonal therapy).We sought a scientific evaluation of the medicinal herbs that might have immunomodulatory and/or anti-tumor effects and could palliate the side-effects (nausea, insomnia, pain and fatigue) of chemo- and radiotherapy in breast …
-
The effect of glucagon-like peptide-2 and intraluminal nutrients on intestinal adaptation in a rat model of short bowel syndrome
… in the management of short bowel syndrome: hormonal therapy with exogenous glucagon-like peptide-2 (GLP-2) and intraluminal nutrient infusion. Both approaches trigger an adaptive response that yields structural and functional intestinal changes to improve nutrient absorptive capacity. This …
-
miRNA Regulation of Skeletal Muscle Hypertrophy
… currently being pursued, including nutrition, hormonal therapy, and genetic selection. One newly developing avenue is using miRNA technologies to change the expression of protein-coding genes. miRNA are a type of RNA that regulate over half of protein-coding gene expression. Here we evaluate …
Page 1 of 5